Literature DB >> 869902

Regulation of mammalian protein synthesis in vivo. Stimulated protein synthesis in liver in vivo after cycloheximide treatment.

J J Ch'ih, R Procyk, T M Devlin.   

Abstract

Protein synthesis in rat liver in vivo was measured between 0 and 72 h after administration of a non-lethal dose of cycloheximide. There was a period of inhibition of [3H]leucine incorporation into both intra- and extra-cellular proteins at 2 h after administration of the drug, which was followed by a recovery phase in which amino acid incorporation varied significantly among the various proteins evaluated. At 12 h there was a marked stimulation of incorporation into nascent polypeptides released from polyribosomes and plasma fibrinogen, but incorporation into ribosomal proteins as well as albumin was still inhibited. Between 12 and 48 h, nascent-polypeptide synthesis remained elevated, but ribosomal-protein synthesis recovered slowly from the inhibition to normal rates only, and plasma-albumin synthesis increased slowly to above control values up to 48 h before returning to normal. A differential pattern of incorporation was also observed for incorporation into free and membrane-bound polyribosomes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869902      PMCID: PMC1164633          DOI: 10.1042/bj1620501

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Alteration in plasma and cellular enzyme and protein levels after lethal and non-lethal doses of cycloheximide in the rat.

Authors:  J J Ch'ih; D M Olszyna; T M Devlin
Journal:  Biochem Pharmacol       Date:  1976-11-01       Impact factor: 5.858

3.  Protein-synthesising activity of free and membrane-bound ribosomes in vitro and their differential sensitivity to protein synthesis inhibitors.

Authors:  A Koffer
Journal:  FEBS Lett       Date:  1974-09-15       Impact factor: 4.124

4.  Ribosomal-membrane interaction: in vitro binding of ribosomes to microsomal membranes.

Authors:  N Borgese; W Mok; G Kreibich; D D Sabatini
Journal:  J Mol Biol       Date:  1974-09-25       Impact factor: 5.469

5.  A plasma protein fractionation procedure for use in studies of protein metabolism.

Authors:  J Ho; K N Jeejeebhoy; R H Painter
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

6.  Preparation and characterization of free and membrane-bound polysomes.

Authors:  H Bloemendal; E L Benedetti; W S Bont
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Biogenesis of mammalian mitochondria in the renoprival kidney. I. Amino acid incorporation and respiratory activity.

Authors:  T M Devlin; J J Ch'ih
Journal:  Arch Biochem Biophys       Date:  1972-10       Impact factor: 4.013

8.  Anomalous stimulation of protein synthesis: evidence for translational control in primary cells.

Authors:  C W Christopher; K Ishikawa; H Amos
Journal:  Cell Tissue Kinet       Date:  1971-01

9.  The acute effect of ethanol on albumin, fibrinogen and transferrin synthesis in the rat.

Authors:  K N Jeejeebhoy; M J Phillips; A Bruce-Robertson; J Ho; U Sodtke
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

10.  Production of membrane whorls in rat liver by some inhibitors of protein synthesis.

Authors:  K M Hwang; L C Yang; C K Carrico; R A Schulz; J B Schenkman; A C Sartorelli
Journal:  J Cell Biol       Date:  1974-07       Impact factor: 10.539

View more
  10 in total

1.  Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures.

Authors:  J Bengzon; Z Kokaia; E Elmér; A Nanobashvili; M Kokaia; O Lindvall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

2.  Regulation of mammalian protein synthesis in vivo. Simulated transport of nuclear ribonucleoprotein complexes to the cytoplasm after cycloheximide treatment.

Authors:  J J Ch'ih; D M Duhl; L S Faulkner; T M Devlin
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

3.  Regulation of mammalian protein synthesis in vivo. Stimulated liver ribonucleic acid synthesis in vivo after cycloheximide treatment.

Authors:  J J Ch'ih; L M Pike; T M Devlin
Journal:  Biochem J       Date:  1977-10-15       Impact factor: 3.857

4.  Acute phase reaction in rats: independent change of acute phase protein plasma concentration and macroscopic inflammation in primary rat adjuvant inflammation.

Authors:  R Hirschelmann; R Schade; H Bekemeier
Journal:  Agents Actions       Date:  1990-06

5.  Effect of a single dose of inducers and inhibitors on the rate of synthesis of cytochromes and reductases in liver organelles.

Authors:  I Raw; P Rockwell
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

6.  Inhibition by cycloheximide of degradation of cytochrome P-450 in primary cultures of adult rat liver parenchymal cells and in vivo.

Authors:  P S Guzelian; J L Barwick
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

7.  Control of cell protein catabolism in rat liver. Effects of starvation and administration of cycloheximide.

Authors:  F M Baccino; L Tessitore; G Cecchini; M Messina; M F Zuretti; G Bonelli; L Gabriel; J S Amenta
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

8.  Cycloheximide as a probe of fibrinogen synthesis.

Authors:  R Procyk; T M Devlin; J J Ch'ih
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

9.  Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.

Authors:  R Cumin; E F Bandle; E Gamzu; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Composition of hnRNA-associated proteins in rat liver is specifically altered after cycloheximide treatment.

Authors:  G Kostka; A Schweiger
Journal:  Mol Biol Rep       Date:  1980-03-31       Impact factor: 2.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.